🔎 Trials Near Me

Inicio › Depresión › Arkansas

Ensayos clínicos de Depresión en Arkansas

10 estudios sobre Depresión buscan participantes en Arkansas.

Ciudades en Arkansas

Texto oficial del estudio (inglés)

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

  • Pillar Clinical Research, Bentonville
  • SanRo Clinical Research Group, Bryant
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 8 sept 2026 · NCT07076407

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

  • Draig Clinical Site, Little Rock
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT07610473

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

  • Draig Clinical Site, Bentonville
  • Draig Clinical Site, Little Rock
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 26 ago 2026 · NCT07300969

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Bryant
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 ago 2026 · NCT06911112

E-Mindfulness Approaches for Living After Breast Cancer

  • Mercy Hospital Fort Smith, Fort Smith
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
  • University of Arkansas for Medical Sciences, Little Rock
ReclutandoFase 3
Edades de 18 a 50 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06748222

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  • Woodland International Research Group, Little Rock
  • Woodland Research Northwest, Rogers
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 3 ago 2026 · NCT06775379

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Bryant
  • Neurocrine Clinical Site, Little Rock
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 jul 2026 · NCT06966401

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  • Pillar Clinical Research, LLC, Little Rock
  • Preferred Research Partners, Inc., Little Rock
  • Woodland Research Northwest, Rogers
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 11 may 2026 · NCT06524830

Effectiveness, Implementation, and Cost of Cognitive Processing Therapy in Prisons

  • University of Arkansas for Medical Sciences, Little Rock
  • Northeast Arkansas Community Corrections Center (NEACC), Osceola
  • Southwest Arkansas Community Correction Center, Texarkana
  • y 1 más
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 ene 2026 · NCT06923423

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Little Rock
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 oct 2025 · NCT06786624

De ClinicalTrials.gov, datos obtenidos el 29 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.